Natural Capsules Limited (NSE:NATCAPSUQ)
India · Delayed Price · Currency is INR 219.55
+9.45 (4.50%)
Last updated: Jul 15, 2025
Natural Capsules Revenue
In the fiscal year ending March 31, 2025, Natural Capsules had annual revenue of 1.69B INR with 8.87% growth. Natural Capsules had revenue of 449.70M in the quarter ending March 31, 2025, with 11.81% growth.
Revenue
1.69B
Revenue Growth
+8.87%
P/S Ratio
1.33
Revenue / Employee
10.01M
Employees
169
Market Cap
2.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.69B | 137.86M | 8.87% |
| Mar 31, 2024 | 1.55B | -169.54M | -9.84% |
| Mar 31, 2023 | 1.72B | 373.09M | 27.62% |
| Mar 31, 2022 | 1.35B | 555.52M | 69.86% |
| Mar 31, 2021 | 795.14M | 179.59M | 29.18% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Mankind Pharma | 122.07B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Glenmark Pharmaceuticals | 134.35B |